[Hiring] Senior Director, Medical Director, Lung Cancer and Early Pipeline @Jazz Pharmaceuticals

Role Description

The Senior Director, Medical Director, Lung Cancer and Early Pipeline will be the Medical Affairs lead for the lung cancer disease area and post proof of concept (POC) pipeline products, including early assets without a defined lead indication globally. They are a key member of Global Commercialization Organization Medical Affairs (GCOMA) Oncology and report to the Executive Director, Solid Tumor Lead.

The Senior Medical Director will be the subject matter expert lead for the Solid Tumor Oncology product, partnering closely with US cross-functional partners to create and execute the US Medical Affairs strategy, including the integrated evidence generation plan. This is a strategic role with execution responsibilities and is accountable for ensuring the needs and priorities of the US region are represented and addressed through engagement with key partners across Jazz.

The Senior Medical Director will partner with the early/clinical development team to determine and align on future treatment landscape scenarios for assets in early development in additional therapeutic areas for early pipeline products without a lead indication and those in new oncology therapeutic areas.

The role serves as a critical interface between Medical Affairs and global R&D, Early/Clinical Development, Global Product Development and Commercialization functions, partnering closely with US colleagues to ensure regional insights and priorities are understood, communicated, and appropriately considered within the Global Product Team (GPT), Commercial Development Team (CDT), Medical Functional Matrix Team (FMT), and governance forums including the Portfolio Governance Committee (PGC) and Development Project Review Committee (DPRC).

Qualifications

• A minimum of 10 years of Medical Affairs, Clinical Development, or related pharmaceutical or biotechnology industry experience is required, preferably in oncology.
• Experience in Lung cancer therapies is strongly preferred.
• Demonstrated experience developing and executing evidence-generation strategies, publication plans, and external scientific engagement activities.
• Strong understanding of clinical research, evidence generation, and drug development.
• Proven ability to influence without authority and operate effectively within complex matrix organizations.
• Strong strategic thinking coupled with excellent operational execution skills.
• Excellent written, verbal, presentation, and stakeholder management skills.
• Ability to build productive partnerships across regions and functions and effectively represent diverse stakeholder perspectives.
• Demonstrated ability to manage multiple priorities and deliver high-quality outcomes in a fast-paced environment.
• Experience in lifecycle management of Lung cancer indications strongly desired.
• Evidence of success in matrix organizations and track record of high performing behaviors, including independent critical thinking, initiative, and execution under time pressure with competing priorities.
• Self-awareness and emotional intelligence as demonstrated by prior experience navigating complex matrix environments successfully.

Requirements

• Advanced scientific or healthcare degree required (PharmD, PhD, MD, MBBS, Nurse Practitioner, PA, or equivalent).
• Experience in the delivery of oncology care preferred.

Benefits

• Medical, dental and vision insurance.
• 401k retirement savings plan.
• Flexible paid vacation.
• Discretionary annual cash bonus or incentive compensation (depending on the role).
• Discretionary equity grants in accordance with Jazz’s Long Term Equity Incentive Plan.